Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Maintenance With Niraparib in Patients With Stage III, Stage IV or Platinum-sensitive Recurrent Uterine Serous Carcinoma

NCT04080284 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT04080284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04080284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Maintenance With Niraparib in Patients With Stage III, Stage IV or Platinum-sensitive Recurrent Uterine Serous Carcinoma
Lead sponsor
Northwell Health
Phase
Phase 2
Overall status
Completed
Start date
December 30, 2019
Completion date
January 1, 2025
Enrollment
22 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the endometrium, endometrial cancer, endometrial carcinoma, papillary serous endometrial carcinoma, uterine serous carcinoma